Audit and use of NSAIDs [13]

Lancet

Volumn 352, Issue 9128, 1998, Pages 658-

  Hawkins, C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; ANTIULCER AGENT;

ADVANCED CANCER; DIGESTIVE SYSTEM ULCER; HIGH RISK PATIENT; HUMAN; LETTER; MEDICAL AUDIT; PRESCRIPTION; PRIORITY JOURNAL; DRUG UTILIZATION; NEOPLASM; RETROSPECTIVE STUDY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; DRUG UTILIZATION; HUMANS; MEDICAL AUDIT; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0032558204     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79620-3     Document Type: Letter

References (4)

1. CJ Hawkey Nonsteroidal anti-inflammatory drug gastropathy, causes and treatment Scand J Gastroenterol 31 suppl 220 1996 124 127
2. RSB Ehsanullah MC Page G Tildesly JR Wood Prevention of gastroduodenal damage induced by non-steroidol anti-infammatory drugs, controlled trial of ranitidine BMJ 297 1988 1017 1021
3. FE Silverstein DY Graham JR Senior Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebocontrolled trial Ann Inern Med 123 1995 241 249
4. P Ekstrom L Carling S Wetterhus Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study Scand J Gastroenterol 31 1996 753 758